208 related articles for article (PubMed ID: 34951690)
21. MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
Kickingereder P; Radbruch A; Burth S; Wick A; Heiland S; Schlemmer HP; Wick W; Bendszus M; Bonekamp D
Radiology; 2016 May; 279(2):542-52. PubMed ID: 26579564
[TBL] [Abstract][Full Text] [Related]
22. A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas.
Hashido T; Saito S; Ishida T
Sci Rep; 2020 Apr; 10(1):6121. PubMed ID: 32273523
[TBL] [Abstract][Full Text] [Related]
23. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma.
Chakhoyan A; Woodworth DC; Harris RJ; Lai A; Nghiemphu PL; Liau LM; Pope WB; Cloughesy TF; Ellingson BM
J Neurooncol; 2018 Sep; 139(3):651-659. PubMed ID: 29855771
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors.
Jiang J; Zhao L; Zhang Y; Zhang S; Yao Y; Qin Y; Wang CY; Zhu W
Int J Clin Exp Pathol; 2014; 7(6):2790-9. PubMed ID: 25031698
[TBL] [Abstract][Full Text] [Related]
25. Correlation of 3D Arterial Spin Labeling and Multi-Parametric Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors.
Khashbat Md D; Abe Md T; Ganbold Md M; Iwamoto Md S; Uyama Md N; Irahara Md S; Otomi Md PhD Y; Harada Md PhD M; Kageji Md PhD T; Nagahiro Md PhD S
J Med Invest; 2016; 63(3-4):175-81. PubMed ID: 27644554
[TBL] [Abstract][Full Text] [Related]
26. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
Ingrisch M; Sourbron S; Herberich S; Schneider MJ; Kümpfel T; Hohlfeld R; Reiser MF; Ertl-Wagner B
Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
[TBL] [Abstract][Full Text] [Related]
27. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
[TBL] [Abstract][Full Text] [Related]
28. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
[TBL] [Abstract][Full Text] [Related]
29. Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial.
Schmainda KM; Prah MA; Marques H; Kim E; Barboriak DP; Boxerman JL
Neuro Oncol; 2021 Feb; 23(2):314-323. PubMed ID: 32678438
[TBL] [Abstract][Full Text] [Related]
30. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
Khalifa J; Tensaouti F; Lotterie JA; Catalaa I; Chaltiel L; Benouaich-Amiel A; Gomez-Roca C; Noël G; Truc G; Péran P; Berry I; Sunyach MP; Charissoux M; Johnson C; Cohen-Jonathan Moyal E; Laprie A
J Neurooncol; 2016 Oct; 130(1):181-192. PubMed ID: 27502603
[TBL] [Abstract][Full Text] [Related]
31. Glioblastoma (GBM) effects on quantitative MRI of contralateral normal appearing white matter.
Mehrabian H; Lam WW; Myrehaug S; Sahgal A; Stanisz GJ
J Neurooncol; 2018 Aug; 139(1):97-106. PubMed ID: 29594656
[TBL] [Abstract][Full Text] [Related]
32. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of the apparent diffusion coefficient for the evaluation of the white matter to differentiate between glioblastoma and brain metastases.
Miquelini LA; Pérez Akly MS; Funes JA; Besada CH
Radiologia; 2016; 58(3):207-13. PubMed ID: 26655126
[TBL] [Abstract][Full Text] [Related]
34. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.
Toh CH; Castillo M; Wong AM; Wei KC; Wong HF; Ng SH; Wan YL
AJNR Am J Neuroradiol; 2008 Mar; 29(3):471-5. PubMed ID: 18065516
[TBL] [Abstract][Full Text] [Related]
35. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
36. Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas.
Khayal IS; McKnight TR; McGue C; Vandenberg S; Lamborn KR; Chang SM; Cha S; Nelson SJ
NMR Biomed; 2009 May; 22(4):449-55. PubMed ID: 19125391
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions.
Sundgren PC; Fan X; Weybright P; Welsh RC; Carlos RC; Petrou M; McKeever PE; Chenevert TL
Magn Reson Imaging; 2006 Nov; 24(9):1131-42. PubMed ID: 17071335
[TBL] [Abstract][Full Text] [Related]
40. Apparent diffusion coefficient measurements in normal appearing white matter may support the differential diagnosis between multiple sclerosis lesions and other white matter hyperintensities.
Zacharzewska-Gondek A; Pokryszko-Dragan A; Gondek TM; Kołtowska A; Gruszka E; Budrewicz S; Sąsiadek M; Bladowska J
J Neurol Sci; 2019 Feb; 397():24-30. PubMed ID: 30580051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
